Tax planning for hematologists with practice equity
If you’re a heme partner with K-1 income, the tax structure is different. Here’s the optimization for partnership-track hematologists.
Author: Pouyan Golshani
Founder of GigHz. Physician, builder, and deep-tech advisor exploring the intersections of advanced materials, medicine, and market strategy. I help innovators refine ideas, connect to the right stakeholders, and bring meaningful solutions to life — one signal at a time.
Buy-and-bill economics for hematology: why PE is rolling up your specialty
Hematology infusion margins are why private equity has been acquiring heme/onc practices. Here’s the economics PE sees and how to evaluate a sale offer.
Hepatology subspecialty economics and CenterIQ liver procedure rates
Hepatology pays differently than general GI. Here’s the rate data for liver procedures and the practice structure considerations.
AI tools for gastroenterology: polyp detection, dictation, and CDS
GI AI has the most clinical-evidence weight of any specialty AI. Here’s the directory of tools with deployment data.
Real estate for gastroenterologists: ASC building + personal portfolio
GI ASC owners often own the building too. Here’s how to layer that with a personal real estate portfolio.
Tax planning for gastroenterologists: ASC equity changes the structure
If you have ASC K-1 income, your tax structure is different from a pure W-2 cardiologist. Here’s the optimization stack.
Endoscopy ASC ownership: the textbook gastroenterology equity story
GI endoscopy ASCs are the cleanest physician-equity story in medicine. Here’s the rate data, the proforma, and the path.
Telemedicine endocrinology: the practice model rewriting the income story
Cash-pay telemedicine endocrinology is becoming a viable full-time model. Here’s the structure, the tax angle, and the patient flow.
AI tools for endocrinology: CGM analytics, insulin titration, and CDS
Endocrinology has more AI tools than the field acknowledges. Here’s the directory.
Real estate for endocrinologists: portfolio building on a primary-care-adjacent income
Endocrinology compensation supports a slower real estate build. Here’s the long-game playbook.